Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal

J Clin Oncol. 2023 Sep 1;41(25):4093-4096. doi: 10.1200/JCO.23.00258. Epub 2023 Jun 23.

Authors

Christine M Bestvina¹, Marina C Garassino¹, Joel W Neal², Heather A Wakelee², Maximilian Diehn³, Everett E Vokes¹

Affiliations

¹ Department of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, Chicago, IL.
² Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.
³ Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.

PMID: 37352477
DOI: 10.1200/JCO.23.00258

No abstract available

MeSH terms

Biomarkers, Tumor / genetics
Carcinoma, Non-Small-Cell Lung* / pathology
Circulating Tumor DNA* / genetics
Humans
Lung Neoplasms* / genetics
Lung Neoplasms* / pathology

Substances

Circulating Tumor DNA
Biomarkers, Tumor

Grants and funding